Aveanna Healthcare Holdings Inc.
NASDAQ:AVAHMedical - Care Facilities
+$0.10 today
- Market cap
- $2.37B
- Beta
- 1.93
- P/E (TTM)
- 6.3
- EPS (TTM)
- $1.22
Volume 2.12M
Average 1.52M
AVAH EBITDA Margin
EBITDA as a percentage of revenue.
Aveanna Healthcare Holdings Inc.NASDAQ: AVAH
EBITDA Margin · Q3 FY2026 · quarter ended Oct 2026
EBITDA Margin widens to 13.7%
EBITDA Margin was 13.7% in Q3 FY2026, up 4.7 pp from a year earlier. On a trailing-twelve-month basis it was 13.0%, up 1.4 pp year over year. Over 3 fiscal years it widened by 40.8 pp.
Context
- EBITDA Margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 7 analysts of 14.8% for the fiscal year ending Jan 2027, up from 11.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterOct 2026
- 13.7%-0.0 pp QoQ
- Last fiscal yearJan 2026
- 11.5%+2.2 pp YoY
- LTMOct 2026
- 13.0%+1.4 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +4.7 pp | +2.1 pp | -2.6 pp |
| 1 year | +2.2 pp | +3.4 pp | +1.2 pp |
| 3 years | +40.8 pp | +3.5 pp | -37.3 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 11.5%
- Year-over-year change
- +2.2pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 11.5% | +2.2pp |
| FY2024 | 2024-12-28 | 9.3% | +7.2pp |
| FY2023 | 2023-12-31 | 2.1% | +31.4pp |
| FY2022 | 2022-12-31 | -29.4% | -28.3pp |
| FY2021 | 2021-12-31 | -1.1% | — |
EBITDA Margin vs competitors
How AVAH compares with its peers on the latest reported figures
- AVAH's LTM Oct 2026 EBITDA Margin of 13.0% is the 4th highest of the 7 companies compared; the peer median is 14.0%.
- Its year-over-year change of +1.4 pp is the highest of 7, against a peer median of +0.1 pp.
- Over three fiscal years its change of +40.8 pp compares with a peer median of +1.6 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 24.2% | +1.1 pp | +3.6 pp | |
| LTM Mar 2026 | 18.5% | +0.7 pp | +1.2 pp | |
| LTM Jun 2026 | 16.6% | -1.4 pp | -1.7 pp | |
| LTM Oct 2026 | 13.0% | +1.4 pp | +40.8 pp | |
| LTM Jun 2026 | 11.3% | +0.7 pp | +2.0 pp | |
| LTM Sep 2026 | 6.9% | -0.5 pp | -0.9 pp | |
| LTM Mar 2026 | 5.9% | -0.7 pp | +2.7 pp | |
| Peer median (excluding AVAH) | 14.0% | +0.1 pp | +1.6 pp | |
Competitors are the stored peer set for AVAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.68B | 1.79B | 1.9B | 2.02B | 2.43B |
| Cost of Revenue | 1.14B | 1.23B | 1.3B | 1.39B | 1.63B |
| Gross Profit | 542.4M | 553.23M | 595.43M | 635.54M | 805.15M |
| Gross Margin | 32.3% | 30.9% | 31.4% | 31.4% | 33.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 419.64M | 483.95M | 464.74M | 470.47M | 526.74M |
| Operating Expenses | 578.52M | 1.2B | 587.36M | 495.76M | 539.77M |
| Depreciation & Amortization | 35.39M | 38.82M | 30.1M | 31.16M | 28.22M |
| EBITDA | (17.96M) | (525.06M) | 39.17M | 187.38M | 279.02M |
| EBITDA Margin | -1.1% | -29.4% | 2.1% | 9.3% | 11.5% |
| Operating Income | (36.11M) | (642.28M) | 8.07M | 139.79M | 265.38M |
| Operating Margin | -2.2% | -35.9% | 0.4% | 6.9% | 10.9% |
| Interest Income | 253K | 679K | 327K | 498K | 2.83M |
| Interest Expense | 68.93M | 107.72M | 153.25M | 156.6M | 140.09M |
| Other Income / Expenses | (77.47M) | (21.54M) | (147.07M) | (134.72M) | (158.43M) |
| Income Before Tax | (113.58M) | (663.81M) | (139M) | 5.07M | 106.95M |
| Pre-Tax Margin | -6.8% | -37.1% | -7.3% | 0.3% | 4.4% |
| Income Tax Expense | 3.47M | (1.78M) | (4.47M) | 16M | (118.09M) |
| Net Income | (117.04M) | (662.03M) | (134.52M) | (10.93M) | 225.03M |
| Net Margin | -7.0% | -37.0% | -7.1% | -0.5% | 9.2% |
| EPS (Basic) | (0.63) | (3.57) | (0.71) | (0.06) | 1.10 |
| EPS (Diluted) | (0.63) | (3.57) | (0.71) | (0.06) | 1.05 |
| Weighted Avg Shares | 184.73M | 185.55M | 189.96M | 192.89M | 203.53M |
| Weighted Avg Shares (Diluted) | 184.73M | 185.55M | 189.96M | 192.89M | 214.98M |
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
Intrinsic Alpha fair value
Locked
Current Price
$10.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.